Relación de la vaginosis bacteriana con el parto y la ruptura de membranas prematuros

1. Hillier SL, Krohn MA, Kelbanoff SJ, Esehenbaeh DA. The relationship of hydrogen peroxide producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gyneeol 1992; 79: 369–373.
2. Priestley CJ, Kinghorn GR. Bacterial vaginosis. Br J Clin Pract 1996; 50: 331–334.
3. Forbes BA, Sahm DF,Weissfeld AS. Genital tract infection. In: Forbes BA, Sahm DF, and Weissfeld AS (eds). Bailey and Scott’s Diagnostic Microbiology, 10th edn. St. Louis: Mosby Company, 1998; 363–379.
4. Greaves WL, Chungafung J, Morris B, Haile A, Townsend JL. Clindamycin versus metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 1988; 72: 799–802.
5. Ferris DG, Litaker MS, Woodward L, Mathis D, Hendrich J. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract 1995; 41: 443–449.
6. Majeroni BA. Bacterial vaginosis: an update. Am Fam Physician 1998; 57: 1285–1289, 1291.
7. Holst E,Wathne B, Hovelius B,Mardh PA. Bacterial vaginosis: microbiological and clinical findings. Eur J Clin Microbiol 1987; 6: 536–541.
8. Catlin BW. Gardnerella vaginalis: characteristics, clinical considerations, and controversies. Clin Microbiol Rev 1992; 5: 213–237.
9. Amsel R, Totten PA, Spiegel CA, Chen KCS, Eschenbach DA, Holmes KK. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14–22.
10. Thomason JL, Gelbart SM, Anderson RJ,Walt AK, Osypowski PJ, Broekhuizen FF. Statistical evaluation of diagnostic criteria for bacterial vaginosis. Am J Obstet Gynecol 1990; 162: 155–160.
11. Gardner HL, Dukes CD. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified ‘nonspecific’ vaginitis. Am J Obstet Gynecol 1955; 69: 962–976.
12. Daniel WW. Biostatics, a foundation for analysis in the health science. New York: John Wiley and Sons, 1993.
13. Clinical Effectiveness Group (Association for Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). National Guideline on the Management of Bacterial Vaginosis. London: Association for Genitourinary Medicine,1999.
14. Hay PE. Therapy of bacterial vaginosis. J Antimicrob Chemother 1998; 41: 6–9.
15. McDonald H, Brocklehurst P, Parsons J. Antibiotics for treating  bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2005; (1): CD000262.
16. Joesoef MR, Schmid GP. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect 1995; 20 (Suppl 1): S72–S79.
17. Sobel JD. Bacterial vaginosis – an ecologic mystery. Ann Intern Med 1989; 111: 551–553.
18. Wain AM. Related Metronidazole vaginal gel 0.75% (MetroGel-Vaginal): a brief review. Infect Dis Obstet Gynecol 1998; 6: 3–7.
19. Sweet RL. New approaches for the treatment of bacterial vaginosis. Am J Obstet Gynecol 1993; 169: 479–482.
20. Locksmith G, Duff P. Infection, antibiotics, and preterm delivery. Semin Perinatol 2001; 25: 295–309.
21. Leyden JJ, Shalita AR, Saatjian GD, Sefton J. Erythromycin 2% gel in comparison with clindamycin phosphate 1% solution in acne vulgaris. J Am Acad Dermatol 1987; 16: 822–827.
22. McGregor JA, French JI, Seo K. Adjunctive clindamycin therapy for preterm labor: results of a double-blind, placebocontrolled trial. Am J Obstet Gynecol 1991; 165: 867–875.
23. Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 1994; 171: 345–349.
24. Philipson A, Sabath LD, Charles D. Transplacental passage of erethromycin and clindamycin. N Engl J Med 1973; 288: 1219–1221.
25. Durfee MA, Forsyth PS, Hale JA, Holmes KK. Ineffectiveness of erythromycin for treatment of Haemophilus vaginalisassociated vaginitis: possible relationship to acidity of vaginal secretions. Antimicrob Agents Chemother 1979; 16: 635–637.
26. Lau AH, Lam NP, Piscitelli SC, Wilkes L, Danzinger LH. Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives. Clin Pharmacokinet 1992; 23: 328–364.
27. Gilstrap LC, Bawdon RE, Burris J. Antibiotic concentration in maternal blood, cord blood, and placental membranes in chorioamnionitis. Obstet Gynecol 1988; 72: 124–125.
28. Scully BE. Metronidazole. Med Clin North Am 1988; 72: 613–621.
29. Hillier SL, Martius J, Krohn MA, Kiviat NB, Holmes KK, Eschenbach DA. Case-control study of chorioamnionic infection and chorioamnionitis in prematurity. N Engl J Med 1988;319: 972–975.
30. Gemmell CG. Antibiotics and expression of microbial virulence factors: implications for host defense. J Chemother 1991;3: 105–111.
31. Gravett MG, Hummel D, Eschenbach DA, Holmes KK. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol 1986; 67:229–237.
32. Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986; 256: 1899–1903.
33. Martius J, Krohn MA, Hillier SL, Stamm WE. Relationships of vaginal lactobacillus species, cervical chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol 1988; 71: 89–95.
34. Platz-Christensen JJ, Mattsby-Baltzer I, Thomsen P, Wiqvist N. Endotoxin and interleukin-1 alpha in the cervical mucus and vaginal fluid of pregnant women with bacterial vaginosis.Am J Obstet Gynecol 1993; 169: 1161–1166.
35. McDonald HM, O’Loughlin JA, Vigneswaran R et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised, placebo controlled trial. Br J Obstet Gynaecol 1997;104: 1391–1397.
36. McGregor JA, French JI, Jones W et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994; 170: 1048–1060.
37. Hillier SL, Holmes KK. Bacterial vaginosis. In: Holmes KK, Mårdh P-A, Sparling PF et al. (eds). Sexually Transmitted Diseases. New York: McGraw-Hill Information Services Co, 1990;547–559.
38. Hill GB, Livengood CH. Bacterial vaginosis-associated microflora and effects of topical intravaginal clindamycin. Am J Obstet Gynecol 1994; 171: 1198–1204.
39. Shennan AH, Crawshaw S, Brilley A et al. A randomized controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin:the PREMET study. Br J Obstet Gynaecol 2006; 113: 65–74.
40. Larsson PG, Fahraeus L, Carlsson B, Jakobsson T, Forsum U; Premature Study Group of the Southeast Health Care Region of Sweden. Latemiscarriage and preterm birth after treatment with clindamycin: a randomised consent design study according to Zelen. BJOG 2006; 113: 629–637.
41. Fischbach F, Petersen EE, Weissenbacher ER, Martius J, Hosmann J, Mayer H. Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 1993; 82: 405–410.
42. Schmitt C, Sobel JD, Meriwether C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol 1992; 79: 1020–1023.
43. Pheifer TA, Forsyth PS, Durfee MA, Pollock HM, Holmes KK. Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole. N Engl J Med 1978; 298: 1429–1434.